Alarum Technologies (NASDAQ:ALAR – Get Free Report) and Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership and analyst recommendations.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Alarum Technologies and Firefly Neuroscience, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Alarum Technologies | 1 | 0 | 1 | 0 | 2.00 |
| Firefly Neuroscience | 1 | 0 | 0 | 0 | 1.00 |
Alarum Technologies presently has a consensus price target of $22.00, suggesting a potential upside of 227.62%. Given Alarum Technologies’ stronger consensus rating and higher probable upside, research analysts plainly believe Alarum Technologies is more favorable than Firefly Neuroscience.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Alarum Technologies | $31.82 million | 1.53 | $5.78 million | $0.17 | 39.50 |
| Firefly Neuroscience | $110,000.00 | 87.78 | -$10.46 million | ($2.09) | -0.32 |
Alarum Technologies has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Alarum Technologies, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
3.2% of Alarum Technologies shares are owned by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are owned by institutional investors. 2.7% of Alarum Technologies shares are owned by insiders. Comparatively, 6.4% of Firefly Neuroscience shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Alarum Technologies and Firefly Neuroscience’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Alarum Technologies | 3.28% | 17.77% | 13.68% |
| Firefly Neuroscience | -2,705.88% | -319.00% | -191.27% |
Volatility & Risk
Alarum Technologies has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Comparatively, Firefly Neuroscience has a beta of 1.91, indicating that its share price is 91% more volatile than the S&P 500.
Summary
Alarum Technologies beats Firefly Neuroscience on 10 of the 14 factors compared between the two stocks.
About Alarum Technologies
Alarum Technologies Ltd. provides internet access and web data collection solutions in North, South, and Central America, Europe, Southeast Asia, the Middle East, and Africa. The company operates through two segments, Enterprise Internet Access Solutions and Consumer Internet Access Solutions. The company offers security blanket against ransomware, viruses, phishing, and other online threats, as well as secured and encrypted connection, masking the customers online activity and keeping them safe from hackers. It also provides privacy solutions and services, a software solution that uses an encryption protocol which is defined upon the process being used to generate a secured encrypted path and keep the users' data private and safe; and web data collection solution allows organizations to collect vast amounts of web and internet data by simultaneously connecting to the Internet from different IP addresses. In addition, the company offers static residential proxy network, rotating residential proxy network, data center proxy network, premium dedicated static residential proxies, mobile proxies, SERP data collection service, and social data collection service, as well as advertising services to enterprise customers. The company offers its products through resellers and internet service providers. It serves advertising and media companies, financial organizations, cyber security companies, industrial and commercial companies, online companies, education institutions, and AI recruitment market and other sectors. The company was formerly known as Safe-T Group Ltd. and changed its name to Alarum Technologies Ltd. in January 2023. Alarum Technologies Ltd. was founded in 2013 and is headquartered in Tel Aviv, Israel.
About Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Receive News & Ratings for Alarum Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alarum Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
